214 results on '"P Dasgupta"'
Search Results
2. Cimetidine in painful bladder syndrome: a histopathological study
- Author
-
H.N. Blackford, C. Womack, P. Dasgupta, S.D. Sharma, and P. Dennis
- Subjects
Pathology ,medicine.medical_specialty ,Urinary bladder ,business.industry ,Urology ,Stomach ,Interstitial cystitis ,medicine.disease ,Transitional cell carcinoma ,medicine.anatomical_structure ,medicine ,G cell ,Cimetidine ,business ,Bladder Pain ,Gastrin ,medicine.drug - Abstract
Objective To determine whether oral cimetidine, which reportedly improves symptoms in 60–70% of patients with painful bladder syndrome/interstitial cystitis has a similar mechanism of action on the human bladder and involving a similar peptidergic pathway as it has in human stomach, where it alters histamine-gastrin reactions mediated via H2 receptors and a proton pump. Patients and methods Fourteen patients (13 women and one man, mean age 51 years) with refractory bladder pain and irritative urinary symptoms were treated with cimetidine. The response to cimetidine was assessed by outpatient follow-up and an analogue pain score. Bladder biopsies from eight patients were stained with haematoxylin and eosin, and a polyclonal antibody to gastrin, with counterstaining using toluidine blue, to detect mast cell granules containing histamine. Biopsies from normal areas of the bladder from an age-matched control group of patients with transitional cell carcinoma of the bladder were stained similarly. Human stomach and colon were used as positive controls for gastrin and toluidine blue, respectively. The clinical response to cimetidine was compared with the histology in a blinded fashion. Results Eight of the patients responded well to cimetidine; none of the biopsies showed evidence of carcinoma in situ. Although G cells in the stomach stained well for gastrin none of the bladder biopsies showed gastrin-like immunoreactivity, apart from some nonspecific urothelial staining. Numerous mast cells with crimson granules and pale nuclei were visible in three patients and fewer in three others; their presence or absence did not correlate with the symptomatic response. Conclusions Cimetidine is a useful medical treatment for bladder pain but the presence or absence of gastrin or histamine-like immunoreactivity does not explain its therapeutic benefit.
- Published
- 2001
3. Trans-oceanic telerobotic surgery
- Author
-
B J, Challacombe, L R, Kavoussi, and P, Dasgupta
- Subjects
Urologic Diseases ,Humans ,Urologic Surgical Procedures ,Robotics ,Global Health ,Telemedicine ,Forecasting - Published
- 2003
4. A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity
- Author
-
M, Harper, R B, Popat, R, Dasgupta, C J, Fowler, and P, Dasgupta
- Subjects
Male ,Neuromuscular Agents ,Needles ,Chronic Disease ,Ambulatory Care ,Urinary Bladder Diseases ,Humans ,Pain ,Female ,Botulinum Toxins, Type A ,Anesthesia, Local ,Injections - Published
- 2003
5. Open vs laparoscopic donor nephrectomy in renal transplantation
- Author
-
P, Dasgupta and S, Kahn
- Subjects
Living Donors ,Tissue and Organ Harvesting ,Humans ,Laparoscopy ,Length of Stay ,Kidney ,Nephrectomy - Published
- 2002
6. Radical prostatectomy in Britain and Ireland at the millennium
- Author
-
S, Ravichandran, P, Dasgupta, and C M, Booth
- Subjects
Male ,Prostatectomy ,Prostatic Diseases ,Consultants ,Attitude of Health Personnel ,Surveys and Questionnaires ,Urology ,Humans ,Professional Practice ,Ireland ,Referral and Consultation ,United Kingdom - Abstract
To report a national questionnaire survey of all consultant urologists, providing a 'snapshot' of attitudes, current practice and referral patterns for radical prostatectomy (RP) in Britain and Ireland at the millennium.During 1999/2000 a simple questionnaire about RP was sent to the 487 urologists registered as full BAUS members. From 418 (86%) returns nine were excluded, to leave a study group of 409 urologists.In all, 157 (38%) consultants were undertaking RP, whilst 252 (62%) were not; 29 (18.5%) performed20 operations/year, 44 (28%) undertook 11-20, but 84 (53.5%) carried outor= 10. During the survey period, 741 (51%) RPs were conducted in teaching hospitals and 724 (49%) in district general hospitals. Of the 252 not undertaking RP, 23 (9%) stated they wished to learn the technique.This questionnaire suggests that the number of urologists undertaking RP in the UK and Ireland has stabilized but confirms that over half performor = 10/year; outcome data are now required. Any change towards concentrating cases will have significant consequences for patient distribution and resources.
- Published
- 2002
7. Robotics in urology: the Ethicon Foundation Fund Travelling Fellowship, the Royal College of Surgeons of Edinburgh
- Author
-
P, Dasgupta
- Subjects
Catheters, Indwelling ,General Surgery ,Urology ,Humans ,Robotics - Published
- 2001
8. Cimetidine in painful bladder syndrome: a histopathological study
- Author
-
P, Dasgupta, S D, Sharma, C, Womack, H N, Blackford, and P, Dennis
- Subjects
Male ,Treatment Outcome ,Histamine H2 Antagonists ,Cystitis, Interstitial ,Urinary Bladder Diseases ,Humans ,Pain ,Female ,Syndrome ,Middle Aged ,Cimetidine ,Follow-Up Studies ,Pain Measurement - Abstract
To determine whether oral cimetidine, which reportedly improves symptoms in 60-70% of patients with painful bladder syndrome/interstitial cystitis has a similar mechanism of action on the human bladder and involving a similar peptidergic pathway as it has in human stomach, where it alters histamine-gastrin reactions mediated via H2 receptors and a proton pump.Fourteen patients (13 women and one man, mean age 51 years) with refractory bladder pain and irritative urinary symptoms were treated with cimetidine. The response to cimetidine was assessed by outpatient follow-up and an analogue pain score. Bladder biopsies from eight patients were stained with haematoxylin and eosin, and a polyclonal antibody to gastrin, with counterstaining using toluidine blue, to detect mast cell granules containing histamine. Biopsies from normal areas of the bladder from an age-matched control group of patients with transitional cell carcinoma of the bladder were stained similarly. Human stomach and colon were used as positive controls for gastrin and toluidine blue, respectively. The clinical response to cimetidine was compared with the histology in a blinded fashion.Eight of the patients responded well to cimetidine; none of the biopsies showed evidence of carcinoma in situ. Although G cells in the stomach stained well for gastrin none of the bladder biopsies showed gastrin-like immunoreactivity, apart from some nonspecific urothelial staining. Numerous mast cells with crimson granules and pale nuclei were visible in three patients and fewer in three others; their presence or absence did not correlate with the symptomatic response.Cimetidine is a useful medical treatment for bladder pain but the presence or absence of gastrin or histamine-like immunoreactivity does not explain its therapeutic benefit.
- Published
- 2001
9. The purse-string suture in nephron-sparing surgery for renal cell carcinoma
- Author
-
P. Dasgupta and A. Rane
- Subjects
Purse string suture ,medicine.medical_specialty ,Renal cell carcinoma ,business.industry ,Urology ,medicine ,Nephron sparing surgery ,medicine.disease ,business ,Surgery - Published
- 2004
10. Inheritance patterns of lower urinary tract symptoms in adults: a systematic review.
- Author
-
Moore L, Raison N, Malde S, Dasgupta P, and Sahai A
- Abstract
Objective: To compile and evaluate the heritability and inheritance patterns of lower urinary tract symptoms (LUTS) in adult cohorts., Methods: Searches of five databases (PubMed, Embase, APA PsycInfo, Global Health, and OVID Medline) commenced on 6 July 2024, resulting in 736 articles retrieved after deduplication. Studies evaluating heritability patterns, gene frequencies, and familial aggregation of symptoms were included for review. Screening and predefined eligibility criteria produced 34 studies for final review. A descriptive analysis of synthesised data was performed, adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The Cochrane Risk of Bias in Non-Randomised Studies of Interventions (ROBINS-I) tool and the Johanna Briggs Institute checklist were used to evaluate these studies., Results: Ten of the 34 studies (29%) described general LUTS, 14 (41%) described symptoms due to benign prostatic enlargement (BPE), nine (26%) described urinary incontinence (UI; urge UI [UUI], stress UI [SUI] and mixed UI [MUI]), four (12%) described nocturia alone, two (6%) described overactive bladder (OAB), and four (13%) described other specific symptoms (frequency, postvoid residual urine volume). BPE symptoms, UI (MUI and UUI), nocturia alone, and frequency alone were associated with genetic predisposition, whilst OAB and SUI had more modest inheritance., Conclusion: The pathogenetic and pharmacological mechanisms fundamental to LUTS manifestation are highly heterogeneous. Further work is required to evaluate the inheritance patterns of LUTS more extensively., (© 2024 The Author(s). BJU International published by John Wiley & Sons Ltd on behalf of BJU International.)
- Published
- 2024
- Full Text
- View/download PDF
11. Idea, Development, Exploration, Assessment, Long-term follow-up study (IDEAL) Stage 1/2a evaluation of urological procedures with the Versius robot.
- Author
-
Reeves F, Challacombe B, Ribbits A, Ourselin S, and Dasgupta P
- Subjects
- Follow-Up Studies, Humans, Robotics
- Published
- 2022
- Full Text
- View/download PDF
12. Assessing the learning curve of single-port robot-assisted prostatectomy.
- Author
-
Reeves F and Dasgupta P
- Subjects
- Humans, Learning Curve, Male, Prostatectomy, Robotic Surgical Procedures, Robotics
- Published
- 2021
- Full Text
- View/download PDF
13. Outcomes in robot-assisted partial nephrectomy for imperative vs elective indications.
- Author
-
Tan JS, Sathianathen N, Cumberbatch M, Dasgupta P, Mottrie A, Abaza R, Ho Rha K, Yuvaraja TB, Parekh DJ, Capitanio U, Ahlawat R, Rawal S, Buffi NM, Sivaraman A, Maes KK, Gautam G, Porpiglia F, Turkeri L, Bhandari M, Challacombe B, Roscoe Porter J, Rogers CR, and Moon DA
- Subjects
- Aged, Aged, 80 and over, Blood Loss, Surgical, Blood Transfusion, Databases, Factual, Elective Surgical Procedures, Female, Glomerular Filtration Rate, Humans, Male, Margins of Excision, Middle Aged, Nephrectomy adverse effects, Operative Time, Postoperative Complications etiology, Propensity Score, Retrospective Studies, Warm Ischemia, Kidney Neoplasms surgery, Nephrectomy methods, Robotic Surgical Procedures adverse effects
- Abstract
Objectives: To assess and compare peri-operative outcomes of patients undergoing robot-assisted partial nephrectomy (RAPN) for imperative vs elective indications., Patient and Methods: We retrospectively reviewed a multinational database of 3802 adults who underwent RAPN for elective and imperative indications. Laparoscopic or open partial nephrectomy (PN) were excluded. Baseline data for age, gender, body mass index, American Society of Anaesthesiologists score and PADUA score were examined. Patients undergoing RAPN for an imperative indication were matched to those having surgery for an elective indication using propensity scores in a 1:3 ratio. Primary outcomes included organ ischaemic time, operating time, estimated blood loss (EBL), rate of blood transfusions, Clavien-Dindo complications, conversion to radical nephrectomy (RN) and positive surgical margin (PSM) status., Results: After propensity-score matching for baseline variables, a total of 304 patients (76 imperative vs 228 elective indications) were included in the final analysis. No significant differences were found between groups for ischaemia time (19.9 vs 19.8 min; P = 0.94), operating time (186 vs 180 min; P = 0.55), EBL (217 vs 190 mL; P = 0.43), rate of blood transfusions (2.7% vs 3.7%; P = 0.51), or Clavien-Dindo complications (P = 0.31). A 38.6% (SD 47.9) decrease in Day-1 postoperative estimated glomerular filtration rate was observed in the imperative indication group and an 11.3% (SD 45.1) decrease was observed in the elective indication group (P < 0.005). There were no recorded cases of permanent or temporary dialysis. There were no conversions to RN in the imperative group, and seven conversions (5.6%) in the elective group (P = 0.69). PSMs were seen in 1.4% (1/76) of the imperative group and in 3.3% of the elective group (7/228; P = 0.69)., Conclusion: We conclude that RAPN is feasible and safe for imperative indications and demonstrates similar outcomes to those achieved for elective indications., (© 2021 The Authors BJU International © 2021 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
14. Negative first follow-up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatment.
- Author
-
Singh S, Sandhu P, Beckmann K, Santaolalla A, Dewan K, Clovis S, Rusere J, Zisengwe G, Challacombe B, Brown C, Cathcart P, Popert R, Dasgupta P, Van Hemelrijck M, and Elhage O
- Subjects
- Aged, Biopsy methods, Disease Progression, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Grading, Risk Assessment, Prostate pathology, Prostatic Neoplasms pathology, Prostatic Neoplasms therapy, Watchful Waiting
- Abstract
Objective: To determine the risk of disease progression and conversion to active treatment following a negative biopsy while on active surveillance (AS) for prostate cancer (PCa)., Patients and Methods: Men on an AS programme at a single tertiary hospital (London, UK) between 2003 and 2018 with confirmed low-intermediate-risk PCa, Gleason Grade Group <3, clinical stage
30% positive cores, magnetic resonance imaging (MRI) Likert score >3/T3 or PSA level of >20 ng/mL. Conversion to treatment included radical or hormonal treatment., Results: Among the 460 eligible patients, 23% had negative follow-up biopsy findings. The median follow-up was 62 months, with one to two repeat biopsies and two MRIs per patient during that period. Negative biopsy findings at first repeat biopsy were associated with decreased risk of converting to active treatment (hazard ration [HR] 0.18, 95% confidence interval [CI] 0.09-0.37; P < 0.001), suspicion of disease progression (HR 0.56, 95% CI: 0.34-0.94; P = 0.029), and upgrading (HR 0.48, 95% CI 0.23-0.99; P = 0.047). Data are limited by fewer men with multiple follow-up biopsies., Conclusion: A negative biopsy finding at the first scheduled follow-up biopsy among men on AS for PCa was strongly associated with decreased risk of subsequent upgrading, clinical or radiological suspicion of disease progression, and conversion to active treatment. A less intense surveillance protocol should be considered for this cohort of patients., (© 2020 The Authors BJU International © 2020 BJU International.) - Published
- 2021
- Full Text
- View/download PDF
15. Multi-institutional validation of a perfused robot-assisted partial nephrectomy procedural simulation platform utilizing clinically relevant objective metrics of simulators (CROMS).
- Author
-
Ghazi A, Melnyk R, Hung AJ, Collins J, Ertefaie A, Saba P, Gurung P, Frye T, Rashid H, Wu G, Mottrie A, Costello T, Dasgupta P, and Joseph J
- Subjects
- Female, Humans, Male, Benchmarking, Computer Simulation, Kidney Neoplasms surgery, Nephrectomy methods, Robotic Surgical Procedures
- Abstract
Objective: To conduct a multi-institutional validation of a high-fidelity, perfused, inanimate, simulation platform for robot-assisted partial nephrectomy (RAPN) using incorporated clinically relevant objective metrics of simulation (CROMS), applying modern validity standards., Materials and Methods: Using a combination of three-dimensional (3D) printing and hydrogel casting, a RAPN model was developed from the computed tomography scan of a patient with a 4.2-cm, upper-pole renal tumour (RENAL nephrometry score 7×). 3D-printed casts designed from the patient's imaging were used to fabricate and register hydrogel (polyvinyl alcohol) components of the kidney, including the vascular and pelvicalyceal systems. After mechanical and anatomical verification of the kidney phantom, it was surrounded by other relevant hydrogel organs and placed in a laparoscopic trainer. Twenty-seven novice and 16 expert urologists, categorized according to caseload, from five academic institutions completed the simulation., Results: Clinically relevant objective metrics of simulators, operative complications, and objective performance ratings (Global Evaluative Assessment of Robotic Skills [GEARS]) were compared between groups using Wilcoxon rank-sum (continuous variables) and parametric chi-squared (categorical variables) tests. Pearson and point-biserial correlation coefficients were used to correlate GEARS scores to each CROMS variable. Post-simulation questionnaires were used to obtain subjective supplementation of realism ratings and training effectiveness., Results: Expert ratings demonstrated the model's superiority to other procedural simulations in replicating procedural steps, bleeding, tissue texture and appearance. A significant difference between groups was demonstrated in CROMS [console time (P < 0.001), warm ischaemia time (P < 0.001), estimated blood loss (P < 0.001)] and GEARS (P < 0.001). Six major intra-operative complications occurred only in novice simulations. GEARS scores highly correlated with the CROMS., Conclusions: This perfused, procedural model offers an unprecedented realistic simulation platform, which incorporates objective, clinically relevant and procedure-specific performance metrics., (© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
16. The #VisualAbstract: just a pretty picture?
- Author
-
Griffin C, Aydin A, and Dasgupta P
- Subjects
- Attention, Computer Graphics, Cross-Sectional Studies, Humans, Information Dissemination methods, Urologic Surgical Procedures, Abstracting and Indexing, Periodicals as Topic, Social Media statistics & numerical data
- Published
- 2021
- Full Text
- View/download PDF
17. Predicting intra-operative and postoperative consequential events using machine-learning techniques in patients undergoing robot-assisted partial nephrectomy: a Vattikuti Collective Quality Initiative database study.
- Author
-
Bhandari M, Nallabasannagari AR, Reddiboina M, Porter JR, Jeong W, Mottrie A, Dasgupta P, Challacombe B, Abaza R, Rha KH, Parekh DJ, Ahlawat R, Capitanio U, Yuvaraja TB, Rawal S, Moon DA, Buffi NM, Sivaraman A, Maes KK, Porpiglia F, Gautam G, Turkeri L, Meyyazhgan KR, Patil P, Menon M, and Rogers C
- Subjects
- Aged, Databases, Factual, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Intraoperative Complications epidemiology, Kidney Neoplasms surgery, Machine Learning, Nephrectomy methods, Postoperative Complications epidemiology, Robotic Surgical Procedures
- Abstract
Objective: To predict intra-operative (IOEs) and postoperative events (POEs) consequential to the derailment of the ideal clinical course of patient recovery., Materials and Methods: The Vattikuti Collective Quality Initiative is a multi-institutional dataset of patients who underwent robot-assisted partial nephectomy for kidney tumours. Machine-learning (ML) models were constructed to predict IOEs and POEs using logistic regression, random forest and neural networks. The models to predict IOEs used patient demographics and preoperative data. In addition to these, intra-operative data were used to predict POEs. Performance on the test dataset was assessed using area under the receiver-operating characteristic curve (AUC-ROC) and area under the precision-recall curve (PR-AUC)., Results: The rates of IOEs and POEs were 5.62% and 20.98%, respectively. Models for predicting IOEs were constructed using data from 1690 patients and 38 variables; the best model had an AUC-ROC of 0.858 (95% confidence interval [CI] 0.762, 0.936) and a PR-AUC of 0.590 (95% CI 0.400, 0.759). Models for predicting POEs were trained using data from 1406 patients and 59 variables; the best model had an AUC-ROC of 0.875 (95% CI 0.834, 0.913) and a PR-AUC 0.706 (95% CI, 0.610, 0.790)., Conclusions: The performance of the ML models in the present study was encouraging. Further validation in a multi-institutional clinical setting with larger datasets would be necessary to establish their clinical value. ML models can be used to predict significant events during and after surgery with good accuracy, paving the way for application in clinical practice to predict and intervene at an opportune time to avert complications and improve patient outcomes., (© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
18. Targeted and systematic cognitive freehand-guided transperineal biopsy: is there still a role for systematic biopsy?
- Author
-
Neale A, Stroman L, Kum F, Jabarkhyl D, Di Benedetto A, Mehan N, Rusere J, Chandra A, Challacombe B, Cathcart P, Dasgupta P, Elhage O, and Popert R
- Subjects
- Adult, Aged, Aged, 80 and over, Biopsy instrumentation, Biopsy methods, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Perineum, Prostate diagnostic imaging, Prostatic Neoplasms diagnostic imaging, Retrospective Studies, Prostate pathology, Prostatic Neoplasms pathology
- Abstract
Objectives: To assess whether targeted cognitive freehand-assisted transperineal biopsies using a Precisionpoint
TM device still require additional systematic biopsies to avoid missing clinically significant prostate cancer, and to investigate the benefit of a quadrant-only biopsy approach to analyse whether a quadrant or extended target of the quadrant containing the target only would have been equivalent to systematic biopsy., Patients and Methods: Patients underwent combined systematic mapping and targeted transperineal prostate biopsies at a single institution. Biopsies were performed using the Precisionpoint device (Perineologic, Cumberland, MD, USA) under either local anaesthetic (58%, 163/282), i.v. sedation (12%, 34/282) or general anaesthetic (30%, 85/282). A mean (range) of 24 (5-42) systematic and 4.2 (1-11) target cores were obtained. Magnetic resonance imaging (MRI) scans were reported using the Likert scale. Clinically significant cancer was defined as Gleason 7 or above. Histopathological results were correlated with the presence of an MRI abnormality within a spatial quadrant and the other adjoining or non-adjoining (opposite) quadrants. Histological concordance with radical prostatectomy specimens was analysed., Results: A total of 282 patients were included in this study. Their mean (range) age was 66.8 (36-80) years, median (range) prostate-specific antigen level 7.4 (0.91-116) ng/mL and mean prostate volume 45.8 (13-150) mL. In this cohort, 82% of cases (230/282) were primary biopsies and 18% (52/282) were patients on surveillance. In all, 69% of biopsies (195/282) were identified to have clinically significant disease (Gleason ≥3 + 4). Any cancer (Gleason ≥3 + 3) was found in 84% (237/282) of patients. Of patients with clinically significant disease, the target biopsies alone picked up 88% (171/195), with systematic biopsy picking up the additional 12% (24/195) that the target biopsies missed. This altered with Likert score; 73% of Likert score 3 disease was detected by target biopsy, 92% of Likert score 4 and 100% of Likert score 5. Target biopsies with additional same-quadrant-only systematic cores picked up 75% (18/24) of significant cancer that was missed on target only, found in the same quadrant as the target., Conclusion: Systematic biopsy is still an important tool when evaluating all patients referred for prostate biopsy, but the need is decreased with increasing suspicion on MRI. Patients with very high suspicion of prostate cancer (Likert score 5) may not require systematic cores, unless representative surrounding biopsies are required for other specific treatments (e.g. focal therapy, or operative planning). More prospective studies are needed to evaluate this in full., (© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.)- Published
- 2020
- Full Text
- View/download PDF
19. Society of Robotic Surgery review: recommendations regarding the risk of COVID-19 transmission during minimally invasive surgery.
- Author
-
Porter J, Blau E, Gharagozloo F, Martino M, Cerfolio R, Duvvuri U, Caceres A, Badani K, Bhayani S, Collins J, Coelho R, Rocco B, Wiklund P, Nathan S, Parra-Davila E, Ortiz-Ortiz C, Maes K, Dasgupta P, and Patel V
- Subjects
- COVID-19, Coronavirus Infections epidemiology, Global Health, Humans, Pneumonia, Viral epidemiology, SARS-CoV-2, Betacoronavirus, Coronavirus Infections transmission, Disease Transmission, Infectious prevention & control, Infection Control standards, Operating Rooms standards, Pandemics, Pneumonia, Viral transmission, Robotic Surgical Procedures standards
- Abstract
Objectives: To determine the risk of COVID-19 transmission during minimally invasive surgical (MIS) procedures METHODS: Surgical society statements regarding the risk of COVID transmission during MIS procedures were reviewed. In addition, the available literature on COVID-19 and other viral transmission in CO2 pneumoperitoneum, as well as the presence of virus in the plume created by electrocautery during MIS was reviewed. The society recommendations were compared to the available literature on the topic to create our review and recommendations to mitigate COVID-19 transmission., Results: The recommendations promulgated by various surgical societies evolved over time as more information became available on COVID-19 transmission. Review of the available literature on the presence of COVID-19 in CO2 pneumoperitoneum was inconclusive. There is no clear evidence of the presence of COVID-19 in plume created by electrocautery. Technologies to reduce CO2 pneumoperitoneum release into the operating room as well as filter viral particles are available and should reduce the exposure risk to operating room personnel., Conclusion: There is no clear evidence of COVID-19 virus in the CO2 used during MIS procedures or in the plume created by electrocautery. Until the presence or absence of COVID-19 viral particles has been clearly established, measures to mitigate CO2 and surgical cautery plume release into the operating room should be performed. Further study on the presence of COVID-19 in MIS pneumoperitoneum and cautery plume is needed., (© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
20. A comparative propensity score-matched analysis of perioperative outcomes of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
- Author
-
Hussein AA, Elsayed AS, Aldhaam NA, Jing Z, Peabody JO, Wijburg CJ, Wagner A, Canda AE, Khan MS, Scherr D, Schanne F, Maatman TJ, Kim E, Mottrie A, Aboumohamed A, Gaboardi F, Pini G, Kaouk J, Yuh B, Rha KH, Hemal A, Palou Redorta J, Badani K, Saar M, Stockle M, Richstone L, Roupret M, Balbay D, Dasgupta P, Menon M, and Guru KA
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Propensity Score, Retrospective Studies, Treatment Outcome, Cystectomy methods, Robotic Surgical Procedures, Urinary Bladder Neoplasms surgery, Urinary Diversion methods
- Abstract
Objective: To compare the perioperative outcomes of intracorporeal (ICUD) vs extracorporeal urinary diversion (ECUD) after robot-assisted radical cystectomy (RARC)., Patients and Methods: We retrospectively reviewed the prospectively maintained International Robotic Cystectomy Consortium (IRCC) database. A total of 972 patients from 28 institutions who underwent RARC were included. Propensity score matching was used to match patients based on age, gender, body mass index (BMI), American Society of Anesthesiologists Score (ASA) score, Charlson Comorbidity Index (CCI) score, prior radiation and abdominal surgery, receipt of neoadjuvant chemotherapy, and clinical staging. Matched cohorts were compared. Multivariate stepwise logistic and linear regression models were fit to evaluate variables associated with receiving ICUD, operating time, 90-day high-grade complications (Clavien-Dindo Classification Grade ≥III), and 90-day readmissions after RARC., Results: Utilisation of ICUD increased from 0% in 2005 to 95% in 2018. The ICUD patients had more overall complications (66% vs 58%, P = 0.01) and readmissions (27% vs 17%, P = 0.01), but not high-grade complications (21% vs 24%, P = 0.22). A more recent RC era and ileal conduit diversion were associated with receiving an ICUD. Higher BMI, ASA score ≥3, and receiving a neobladder were associated with longer operating times. Shorter operating time was associated with male gender, older age, ICUD, and centres with a larger annual average RC volume. Longer intensive care unit stay was associated with 90-day high-grade complications. Higher CCI score, prior radiation therapy, neoadjuvant chemotherapy, and ICUD were associated with a higher risk of 90-day readmissions., Conclusions: Utilisation of ICUD has increased over the past decade. ICUD was associated with more overall complications and readmissions compared to ECUD, but not high-grade complications., (© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
21. Long live the BJUI.
- Author
-
Dasgupta P
- Subjects
- History, 20th Century, Humans, Internet history, Periodicals as Topic history, Urology history
- Published
- 2020
- Full Text
- View/download PDF
22. Simulation in Urological Training and Education (SIMULATE): Protocol and curriculum development of the first multicentre international randomized controlled trial assessing the transferability of simulation-based surgical training.
- Author
-
Aydin A, Ahmed K, Van Hemelrijck M, Ahmed HU, Khan MS, and Dasgupta P
- Subjects
- Humans, Learning Curve, Prospective Studies, Clinical Competence, Computer Simulation, Curriculum, Randomized Controlled Trials as Topic methods, Simulation Training methods, Urologic Surgical Procedures education, Urology education
- Abstract
Objectives: To report the study protocol for the first international multicentre randomized controlled trial investigating the effectiveness of simulation-based surgical training and the development process for an evidence-based training curriculum, to be delivered as an educational intervention., Participants and Methods: This prospective, international, multicentre randomized controlled clinical and educational trial will recruit urology surgical trainees who must not have performed ≥10 of the selected index procedure, ureterorenoscopy (URS). Participants will be randomized to simulation-based training (SBT) or non-simulation-based training (NSBT), the latter of which is the current sole standard of training globally. The primary outcome is the number of procedures required to achieve proficiency, where proficiency is defined as achieving a learning curve plateau of 28 or more on an Objective Structured Assessment of Technical Skills (OSATS) assessment scale, for three consecutive operations, without any complications. All participants will be followed up either until they complete 25 procedures or for 18 months. Development of the URS SBT curriculum took place through a two-round Delphi process., Results: A total of 47 respondents, consisting of trainees (n = 24) with URS experience and urolithiasis specialists (n = 23), participated in round 1 of the Delphi process. Specialists (n = 10) finalized the content of the curriculum in round 2. The developed interventional curriculum consists of initial theoretic knowledge through didactic lectures followed by select tasks and cases on the URO-Mentor (Simbionix, Lod, Israel) VR Simulator, Uro-Scopic Trainer (Limbs & Things, Bristol, UK) and Scope Trainer (Mediskills, Manchester, UK) models for both semi-rigid and flexible URS. Respondents also selected relevant non-technical skills scenarios and cadaveric simulation tasks as additional components, with delivery subject to local availability., Conclusions: SIMULATE is the first multicentre trial investigating the effect and transferability of supplementary SBT on operating performance and patient outcomes. An evidence-based training curriculum is presented, developed with expert and trainee input. Participants will be followed and the primary outcome, number of procedures required to proficiency, will be reported alongside key clinical secondary outcomes, (ISCRTN 12260261)., (© 2020 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International.)
- Published
- 2020
- Full Text
- View/download PDF
23. Single-port robot-assisted radical prostatectomy: a systematic review and pooled analysis of the preliminary experiences.
- Author
-
Checcucci E, De Cillis S, Pecoraro A, Peretti D, Volpi G, Amparore D, Piramide F, Piana A, Manfredi M, Fiori C, Autorino R, Dasgupta P, and Porpiglia F
- Subjects
- Humans, Male, Operative Time, Margins of Excision, Prostate surgery, Prostatectomy methods, Prostatic Neoplasms secondary, Robotic Surgical Procedures methods
- Abstract
Objective: To summarize the clinical experiences with single-port (SP) robot-assisted radical prostatectomy (RARP) reported in the literature and to describe the peri-operative and short-term outcomes of this procedure., Material and Methods: A systematic review of the literature was performed in December 2019 using Medline (via PubMed), Embase (via Ovid), Cochrane databases, Scopus and Web of Science (PROSPERO registry number 164129). All studies that reported intra- and peri-operative data on SP-RARP were included. Cadaveric series and perineal or partial prostatectomy series were excluded., Results: The pooled mean operating time, estimated blood loss, length of hospital stay and catheterization time were 190.55 min, 198.4 mL, 1.86 days and 8.21 days, respectively. The pooled mean number of lymph nodes removed was 8.33, and the pooled rate of positive surgical margins was 33%. The pooled minor complication rate was 15%. Only one urinary leakage and one major complication (transient ischaemic attack) were recorded. Regarding functional outcomes, pooled continence and potency rates at 12 weeks were 55% and 42%, respectively., Conclusions: The present analysis confirms that SP-RARP is safe and feasible. This novel robotic platform resulted in similar intra-operative and peri-operative outcomes to those obtained with the standard multiport da Vinci system. The advantages of single incision can be translated into a preservation of the patient's body image and self-esteem and cosmesis, which have a great impact on a patient's quality of life., (© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
24. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
- Author
-
Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D, Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A, Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP, Kaouk J, and Derweesh IH
- Subjects
- Carcinoma, Renal Cell diagnosis, Disease-Free Survival, Female, Humans, Kidney Neoplasms diagnosis, Male, Middle Aged, Retrospective Studies, Tomography, X-Ray Computed, Treatment Outcome, Carcinoma, Renal Cell surgery, Kidney Neoplasms surgery, Neoplasm Staging methods, Nephrectomy methods, Propensity Score, Robotic Surgical Procedures methods
- Abstract
Objective: To compare outcomes of minimally invasive radical nephrectomy (MIS-RN) and robot-assisted partial nephrectomy (RAPN) in clinical T2a renal mass (cT2aRM)., Patients and Methods: Retrospective, multicentre, propensity score-matched (PSM) comparison of RAPN and MIS-RN for cT2aRM (T2aN0M0). Cohorts were PSM for age, sex, body mass index, American Society of Anesthesiologists (ASA) class, clinical tumour size, and R.E.N.A.L. score using a 2:1 ratio for RN:PN. The primary outcome was disease-free survival (DFS). Secondary outcomes included overall survival (OS), complication rates, and de novo estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m
2 . Multivariable (MVA) and Kaplan-Meier survival analyses (KMSA) were conducted., Results: In all, 648 patients (216 RAPN/432 MIS-RN) were matched. There were no significant differences in intraoperative complications (P = 0.478), Clavien-Dindo Grade ≥III complications (P = 0.063), and re-admissions (P = 0.238). The MVA revealed high ASA class (hazard ratio [HR] 2.7, P = 0.044) and sarcomatoid (HR 5.3, P = 0.001), but not surgery type (P = 0.601) to be associated with all-cause mortality. Increasing R.E.N.A.L. score (HR 1.31, P = 0.037), high tumour grade (HR 2.5, P = 0.043), and sarcomatoid (HR 2.8, P = 0.02) were associated with recurrence, but not surgery (P = 0.555). Increasing age (HR 1.1, P < 0.001) and RN (HR 3.9, P < 0.001) were predictors of de novo eGFR of <45 mL/min/1.73 m2 . Comparing RAPN and MIS-RN, KMSA revealed no significant differences for 5-year OS (76.3% vs 88.0%, P = 0.221) and 5-year DFS (78.6% vs 85.3%, P = 0.630) for pT2 RCC, and no differences for 3-year OS (P = 0.351) and 3-year DFS (P = 0.117) for pT3a upstaged RCC. The 5-year freedom from de novo eGFR of <45 mL/min/1.73 m2 was 91.6% for RAPN vs 68.9% for MIS-RN (P < 0.001)., Conclusions: RAPN had similar oncological outcomes and morbidity profile as MIS-RN, while conferring functional benefit. RAPN may be considered as a first-line option for cT2aRM., (© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.)- Published
- 2020
- Full Text
- View/download PDF
25. The genetic landscapes of urological cancers and their clinical implications in the era of high-throughput genome analysis.
- Author
-
Light A, Ahmed A, Dasgupta P, and Elhage O
- Subjects
- Humans, DNA, Neoplasm genetics, Genome-Wide Association Study methods, Urologic Neoplasms genetics
- Abstract
Objective: With the advent of high-throughput genome analysis, we are increasingly able to sequence and hence understand the pathogenic processes underlying individual cancers. Recently, consortiums such as The Cancer Genome Atlas (TCGA) have performed large-scale projects to this end, providing significant amounts of information regarding the genetic landscapes of several cancers., Patients and Methods: We performed a narrative review of studies from the TCGA and other major studies. We aimed to summarise data exploring the clinical implications of specific genetic alterations, both prognostically and therapeutically, in four major urological cancers. These were renal cell carcinoma, muscle-invasive bladder cancer/carcinoma, prostate cancer, and testicular germ cell tumours., Results: With these four urological cancers, great strides have been made in the molecular characterisation of tumours. In particular, recent studies have focussed on identifying molecular subtypes of tumours with characteristic genetic alterations and differing prognoses. Other prognostic alterations have also recently been identified, including those pertaining to epigenetics and microRNAs. In regard to treatment, numerous options are emerging for patients with these cancers such as including immune checkpoint inhibition, epigenetic-based treatments, and agents targeting MAPK, PI3K, and DNA repair pathways. There are a multitude of trials underway investigating the effects of these novel agents, the results of which are eagerly awaited., Conclusions: As medicine chases the era of personalised care, it is becoming increasingly important to provide individualised prognoses for patients. Understanding how specific genetic alterations affects prognosis is key for this. It will also be crucial to provide highly targeted treatments against the specific genetics of a patient's tumour. With work performed by the TCGA and other large consortiums, these aims are gradually being achieved. Our review provides a succinct overview of this exciting field that may underpin personalised medicine in urological oncology., (© 2020 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International.)
- Published
- 2020
- Full Text
- View/download PDF
26. Robot-assisted vs open radical cystectomy for bladder cancer in adults.
- Author
-
Rai BP, Bondad J, Vasdev N, Adshead J, Lane T, Ahmed K, Khan MS, Dasgupta P, Guru K, Chlosta PL, and Aboumarzouk OM
- Subjects
- Aged, Cystectomy adverse effects, Cystectomy statistics & numerical data, Humans, Male, Middle Aged, Postoperative Complications, Quality of Life, Randomized Controlled Trials as Topic, Robotic Surgical Procedures adverse effects, Robotic Surgical Procedures statistics & numerical data, Treatment Outcome, Cystectomy methods, Robotic Surgical Procedures methods, Urinary Bladder Neoplasms surgery
- Abstract
Background: It has been suggested that, in comparison with open radical cystectomy (ORC), robot-assisted radical cystectomy (RARC) results in less blood loss, shorter convalescence and fewer complications, with equivalent short-term oncological and functional outcomes; however, uncertainty remains as to the magnitude of these benefits., Objectives: To assess the effects of RARC vs ORC in adults with bladder cancer., Search Methods: We conducted a comprehensive search, with no restrictions on language of publication or publication status, for randomized controlled trials (RCTs) that compared RARC with ORC. The date of the last search was 1 July 2018. Databases searched included the Cochrane Central Register of Controlled Trials, MEDLINE (1999 to July 2018), PubMed Embase (1999 to July 2018), Web of Science (1999 to July 2018), Cancer Research UK (www.cancerresearchuk.org/), and the Institute of Cancer Research (www.icr.ac.uk/). We also searched the following trial registers: ClinicalTrials.gov (clinicaltrials.gov/); BioMed Central International Standard Randomized Controlled Trials Number (ISRCTN) Registry (www.isrctn.com); and the World Health Organization International Clinical Trials Registry Platform. The review was based on a published protocol. Primary outcomes of the review were recurrence-free survival and major postoperative complications (Clavien grade III to V). Secondary outcomes were minor postoperative complications (Clavien grades I and II), transfusion requirement, length of hospital stay (days), quality of life, and positive surgical margins (%). Three review authors independently assessed relevant titles and abstracts of records identified by the literature search to determine which studies should be assessed further. Two review authors assessed risk of bias using the Cochrane risk-of-bias tool and rated the quality of evidence according to GRADE. We used Review Manager 5 to analyse the data., Results: We included in the review five RCTs comprising a total of 541 participants. Total numbers of participants included in the ORC and RARC cohorts were 270 and 271, respectively. We found that RARC and ORC may result in a similar time to recurrence (hazard ratio 1.05, 95% confidence interval [CI] 0.77 to 1.43; two trials, low-certainty evidence). In absolute terms at 5 years of follow-up, this corresponds to 16 more recurrences per 1000 participants (95% CI 79 fewer to 123 more) with 431 recurrences per 1000 participants for ORC. We downgraded the certainty of evidence because of study limitations and imprecision. RARC and ORC may result in similar rates of major complications (risk ratio [RR] 1.06, 95% CI 0.76 to 1.48; five trials, low-certainty evidence). This corresponds to 11 more major complications per 1000 participants (95% CI 44 fewer to 89 more). We downgraded the certainty of evidence because of study limitations and imprecision. We were very uncertain whether RARC reduces minor complications (very-low-certainty evidence). We downgraded the certainty of evidence because of study limitations and very serious imprecision. RARC probably results in substantially fewer transfusions than ORC (RR 0.58, 95% CI 0.43 to 0.80; two trials, moderate-certainty evidence). This corresponds to 193 fewer transfusions per 1000 participants (95% CI 262 fewer to 92 fewer) based on 460 transfusion per 1000 participants for ORC. We downgraded the certainty of evidence because of study limitations. RARC may result in a slightly shorter hospital stay than ORC (mean difference -0.67, 95% CI -1.22 to -0.12; five trials, low-certainty evidence). We downgraded the certainty of evidence because of study limitations and imprecision. RARC and ORC may result in a similar quality of life (standardized mean difference 0.08, 95% CI 0.32 lower to 0.16 higher; three trials, low-certainty evidence). We downgraded the certainty of evidence because of study limitations and imprecision. RARC and ORC may result in similar positive surgical margin rates (RR 1.16, 95% CI 0.56 to 2.40; five trials, low-certainty evidence). This corresponds to eight more (95% CI 21 fewer to 67 more) positive surgical margins per 1000 participants, based on 48 positive surgical margins per 1000 participants for ORC. We downgraded the certainty of evidence because of study limitations and imprecision., Conclusions: We conclude that RARC and ORC may have similar outcomes with regard to time to recurrence, rates of major complications, quality of life, and positive surgical margin rates (all low-certainty evidence). We are very uncertain whether the robotic approach reduces rates of minor complications (very-low-certainty evidence), although it probably reduces the risk of blood transfusions substantially (moderate-certainty evidence) and may reduce hospital stay slightly (low-certainty evidence). We were unable to conduct any of the preplanned subgroup analyses to assess the impact of patient age, pathological stage, body habitus, or surgeon expertise on outcomes. This review did not address issues of cost-effectiveness., (© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
27. Slowdown of urology residents' learning curve during the COVID-19 emergency.
- Author
-
Porpiglia F, Checcucci E, Amparore D, Verri P, Campi R, Claps F, Esperto F, Fiori C, Carrieri G, Ficarra V, Mario Scarpa R, and Dasgupta P
- Subjects
- Betacoronavirus, COVID-19, Humans, SARS-CoV-2, Teaching, Coronavirus Infections epidemiology, Internship and Residency, Learning Curve, Pandemics, Pneumonia, Viral epidemiology, Urologic Surgical Procedures education
- Published
- 2020
- Full Text
- View/download PDF
28. Global challenges to urology practice during the COVID-19 pandemic.
- Author
-
Ahmed K, Hayat S, and Dasgupta P
- Subjects
- Betacoronavirus, COVID-19, Elective Surgical Procedures, Humans, SARS-CoV-2, Triage, United Kingdom epidemiology, United States epidemiology, Urologic Diseases diagnosis, Urologic Diseases surgery, Coronavirus Infections epidemiology, Pandemics, Pneumonia, Viral epidemiology, Urologic Surgical Procedures
- Published
- 2020
- Full Text
- View/download PDF
29. Bolstering the surgical response to COVID-19: how virtual technology will save lives and safeguard surgical practice.
- Author
-
Karim JS, Hachach-Haram N, and Dasgupta P
- Subjects
- Betacoronavirus, COVID-19, Elective Surgical Procedures, Humans, SARS-CoV-2, Coronavirus Infections epidemiology, Pandemics, Pneumonia, Viral epidemiology, Telemedicine, Urologic Surgical Procedures
- Published
- 2020
- Full Text
- View/download PDF
30. COVID-19 and urology: a comprehensive review of the literature.
- Author
-
Puliatti S, Eissa A, Eissa R, Amato M, Mazzone E, Dell'Oglio P, Sighinolfi MC, Zoeir A, Micali S, Bianchi G, Patel V, Wiklund P, Coelho RF, Bernhard JC, Dasgupta P, Mottrie A, and Rocco B
- Subjects
- Betacoronavirus physiology, COVID-19, Elective Surgical Procedures, Global Health, Humans, SARS-CoV-2, Triage, Urinary Tract microbiology, Coronavirus Infections epidemiology, Pandemics, Pneumonia, Viral epidemiology, Urologic Surgical Procedures
- Abstract
Objective: To discuss the impact of COVID-19 on global health, particularly on urological practice and to review some of the available recommendations reported in the literature., Material and Methods: In the current narrative review the PubMed database was searched to identify all the related reports discussing the impact of COVID-19 on the urological field., Results: The COVID-19 pandemic is the latest and biggest global health threat. Medical and surgical priorities have changed dramatically to cope with the current challenge. These changes include postponements of all elective outpatient visits and surgical procedures to save facilities and resources for urgent cases and patients with COVID-19 patients. This review discuss some of the related changes in urology., Conclusions: Over the coming weeks, healthcare workers including urologists will be facing increasingly difficult challenges, and consequently, they should adopt triage strategy to avoid wasting of medical resources and they should endorse sufficient protection policies to guard against infection when dealing with COVID-19 patients., (© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
31. Covid-19 and urology.
- Author
-
Dasgupta P
- Subjects
- COVID-19, Coronavirus Infections, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2, Betacoronavirus, Neoplasms, Urology
- Published
- 2020
- Full Text
- View/download PDF
32. Development and content validation of the Urethroplasty Training and Assessment Tool (UTAT) for dorsal onlay buccal mucosa graft urethroplasty.
- Author
-
Jasionowska S, Shabbir M, Brunckhorst O, Khan MS, Manzoor H, Dasgupta P, Anderson P, Barbagli G, and Ahmed K
- Subjects
- Adult, Follow-Up Studies, Humans, Male, Middle Aged, Plastic Surgery Procedures methods, Urologic Surgical Procedures, Male methods, Education, Medical, Graduate methods, Mouth Mucosa transplantation, Plastic Surgery Procedures education, Urethra surgery, Urethral Stricture surgery, Urologic Surgical Procedures, Male education, Urology education
- Abstract
Objectives: To develop and validate the Urethroplasty Training and Assessment Tool (UTAT) using Healthcare Failure Mode and Effect Analysis (HFMEA) for training and assessment of urology trainees learning this urethral reconstruction technique, as urethroplasty is the 'gold standard' treatment for long and recurrent urethral strictures and with a variety of techniques and a lack of standardised reconstructive curricula, there is a need for procedure-specific training tools to improve surgeon training and patient safety., Materials and Methods: This international observational study was performed over an 11-month period. The HFMEA was used to identify and evaluate hazardous stages of urethroplasty to develop the UTAT. Hazard scores were calculated for the included steps of urethroplasty. Content validation was performed by 12 expert surgeons and multidisciplinary teams from international tertiary centres., Results: The HFMEA process resulted in an internationally validated UTAT. Hazard scores ≥4 and single point weaknesses were included to implement actions and outcome measures. Content validation was achieved by circulating the process map, hazard analysis table, and developed tools. Changes were implemented based on the feedback received from expert surgeons. The content validated dorsal onlay buccal mucosa graft bulbar UTAT contained five phases, 10 processes and 23 sub-processes., Conclusions: The modular UTAT offers a comprehensive validated training tool developed via a detailed HFMEA protocol. This may be utilised to standardise the training and assessment of urology trainees., (© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
33. Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells.
- Author
-
Sakellariou C, Elhage O, Papaevangelou E, Giustarini G, Esteves AM, Smolarek D, Smith RA, Dasgupta P, and Galustian C
- Subjects
- Cell Line, Tumor, Cells, Cultured, Humans, Male, Interleukin-15 physiology, Killer Cells, Natural physiology, Prostatic Neoplasms pathology
- Abstract
Objectives: To identify cytokines that can activate and expand NK cells in the presence of prostate cancer cells in order to determine whether these agents may be useful in future intra-tumoural administration in pre-clinical and clinical prostate cancer trials., Materials and Methods: Lymphocytes isolated from normal donor blood were set up in co-cultures with either cancer or non-cancerous prostate cell lines, together with each of the cytokines interleukin (IL)-2, IL-12, IL-15, interferon (IFN)-γ or IL-21 for a period of 7 days. Then, expansion of NK cells, NKT cells and CD8 T cells was measured by flow cytometry and compared with the expansion of the same cells in the absence of prostate cells. The cytotoxic activity of NK cells, as measured by perforin and tumour cell killing, was also assessed. NK cell receptors and their corresponding ligands on prostate tumour cells were analysed to determine whether any of these were modulated by co-culture. The role of the tumour-secreted heat shock proteins HSP90 and HSP70 in the expansion of NK cells in the co-cultures was also investigated because of their effects on NK and CD8 T-cell activation., Results: We showed that, among a panel of cytokines known to cause NK cell activation and expansion, only IL-15 could actively induce expansion of NK, NKT and CD8 T cells in the presence of prostate cancer cell lines. Furthermore, the expansion of NK cells was far greater (up to 50% greater) in the presence of the cancer cells (LNCaP, PC3) than when lymphocytes were incubated alone. In contrast, non-cancerous cell lines (PNT2 and WPMY-1) did not exert any expansion of NK cells. The cytolytic activity of the NK cells, as measured by perforin, CD107a and killing of tumour cells, was also greatest in co-cultures with IL-15. Examination of NK cell receptors shows that NKG2D is upregulated to a greater degree in the presence of prostate cancer cells, compared with the upregulation with IL-15 in lymphocytes alone. However, blocking of NKG2D does not inhibit the enhanced expansion of NK cells in the presence of tumour cells., Conclusions: Among a panel of NK cell-activating cytokines, IL-15 was the only cytokine that could stimulate expansion of NK cells in the presence of prostate cancer cells; therefore IL-15 may be a good candidate for novel future intra-tumoural therapy of the disease., (© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
34. The benefits of regular exercise.
- Author
-
Dasgupta P
- Subjects
- Humans, Exercise, Healthy Lifestyle
- Published
- 2020
- Full Text
- View/download PDF
35. Current applications of three-dimensional printing in urology.
- Author
-
Chen MY, Skewes J, Desselle M, Wong C, Woodruff MA, Dasgupta P, and Rukin NJ
- Subjects
- Humans, Bioprinting, Printing, Three-Dimensional, Urologic Surgical Procedures methods, Urology education
- Abstract
Three-dimensional (3D) printing or additive manufacturing is a new technology that has seen rapid development in recent years with decreasing costs. 3D printing allows the creation of customised, finely detailed constructs. Technological improvements, increased printer availability, decreasing costs, improved cell culture techniques, and biomaterials have enabled complex, novel and individualised medical treatments to be developed. Although the long-term goal of printing biocompatible organs has not yet been achieved, major advances have been made utilising 3D printing in biomedical engineering. In this literature review, we discuss the role of 3D printing in relation to urological surgery. We highlight the common printing methods employed and show examples of clinical urological uses. Currently, 3D printing can be used in urology for education of trainees and patients, surgical planning, creation of urological equipment, and bioprinting. In this review, we summarise the current applications of 3D-printing technology in these areas of urology., (© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
36. Retzius-sparing robot-assisted radical prostatectomy vs the standard approach: a systematic review and analysis of comparative outcomes.
- Author
-
Checcucci E, Veccia A, Fiori C, Amparore D, Manfredi M, Di Dio M, Morra I, Galfano A, Autorino R, Bocciardi AM, Dasgupta P, and Porpiglia F
- Subjects
- Humans, Male, Treatment Outcome, Organ Sparing Treatments, Prostatectomy methods, Robotic Surgical Procedures methods
- Abstract
Objectives: To summarize the current evidence on Retzius-sparing (RS)-robot-assisted radical prostatectomy (RARP) and to compare its oncological, peri-operative and functional outcomes with those of standard retropubic RARP (S-RARP)., Materials and Methods: After establishing an a priori protocol, a systematic electronic literature search was conducted in January 2019 using the Medline (via PubMed), Embase (via Ovid) and Cochrane databases. The search strategy relied on the 'PICO' (Patient Intervention Comparison Outcome) criteria and article selection was carried out in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Only studies reporting the oncological and functional outcomes of RARP (as determined by type of procedure [RS-RARP vs S-RARP]) were considered for inclusion. Risk of bias and study quality were assessed. Finally, peri-operative and functional outcomes were recorded and analysed., Results: A shorter operating time was associated with RS-RARP (weighted mean difference [WMD] 14.7 min, 95% confidence interval [CI] -28.25, 1.16; P = 0.03), whereas no significant difference was found in terms of estimated blood loss (WMD 1.45 mL, 95% CI -31.18, 34.08; P = 0.93). Also, no significant difference between the two groups was observed for overall (odds ratio [OR] 0.86, 95% CI 0.40, 1.85; P = 0.71) and major (Clavien >3; OR 0.88, 95% CI 0.30, 2.57) postoperative complications; however, the likelihood of positive surgical margins (PSMs) was lower for the S-RARP group (rate 15.2% vs 24%; OR 1.71, 95% CI 1.12, 2.60; P = 0.01). The cumulative analysis showed a statistically significant advantage for RS-RARP in terms of continence recovery at 1 month (OR 2.54, 95% CI 1.16, 5.53; P = 0.02), as well as at 3 months (OR 3.86, 95% CI 2.23, 6.68; P < 0.001), 6 months (OR 3.61, 95% CI 1.88, 6.91; P = 0.001), and 12 months (OR 7.29, 95% CI 1.89, 28.13; P = 0.004)., Conclusion: Our analysis confirms that RS-RARP is a safe and feasible alternative to S-RARP. This novel approach may be associated with faster and higher recovery of continence, without increasing the risk of complications. One caveat might be the higher risk of PSMs, and this can be regarded as a current pitfall of the technique, probably related to an expected learning curve., (© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
37. High ductal proportion predicts biochemical recurrence in prostatic ductal adenocarcinoma.
- Author
-
Harkin T, Elhage O, Chandra A, Khan N, Kiberu Y, Frydenberg M, and Dasgupta P
- Subjects
- Cohort Studies, Humans, Male, Prostate pathology, Prostate surgery, Prostatectomy, Recurrence, Carcinoma, Ductal mortality, Carcinoma, Ductal pathology, Carcinoma, Ductal surgery, Prostatic Neoplasms mortality, Prostatic Neoplasms pathology, Prostatic Neoplasms surgery
- Published
- 2019
- Full Text
- View/download PDF
38. Artificial intelligence, three-dimensional printing and global health.
- Author
-
Dasgupta P
- Subjects
- Humans, Artificial Intelligence, Global Health, Printing, Three-Dimensional, Urology
- Published
- 2019
- Full Text
- View/download PDF
39. BJUI Compass and open access.
- Author
-
Dasgupta P and Davis JW
- Subjects
- Humans, Internet, Open Access Publishing, Periodicals as Topic, Urology organization & administration
- Published
- 2019
- Full Text
- View/download PDF
40. Current status of artificial intelligence applications in urology and their potential to influence clinical practice.
- Author
-
Chen J, Remulla D, Nguyen JH, Dua A, Liu Y, Dasgupta P, and Hung AJ
- Abstract
Objective: To investigate the applications of artificial intelligence (AI) in diagnosis, treatment and outcome predictionin urologic diseases and evaluate its advantages over traditional models and methods., Materials and Methods: A literature search was performed after PROSPERO registration (CRD42018103701) and in compliance with Preferred Reported Items for Systematic Reviews and Meta-Analyses (PRISMA) methods. Articles between 1994 and 2018 using the search terms "urology", "artificial intelligence", "machine learning" were included and categorized by the application of AI in urology. Review articles, editorial comments, articles with no full-text access, and nonurologic studies were excluded., Results: Initial search yielded 231 articles, but after excluding duplicates and following full-text review and examination of article references, only 111 articles were included in the final analysis. AI applications in urology include: utilizing radiomic imaging or ultrasonic echo data to improve or automate cancer detection or outcome prediction, utilizing digitized tissue specimen images to automate detection of cancer on pathology slides, and combining patient clinical data, biomarkers, or gene expression to assist disease diagnosis or outcome prediction. Some studies employed AI to plan brachytherapy and radiation treatments while others used video based or robotic automated performance metrics to objectively evaluate surgical skill. Compared to conventional statistical analysis, 71.8% of studies concluded that AI is superior in diagnosis and outcome prediction., Conclusion: AI has been widely adopted in urology. Compared to conventional statistics AI approaches are more accurate in prediction and more explorative for analyzing large data cohorts. With an increasing library of patient data accessible to clinicians, AI may help facilitate evidence-based and individualized patient care., (© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
41. The impact of non-urothelial variant histology on oncological outcomes following radical cystectomy.
- Author
-
Stroman L, Nair R, Russell B, Malik N, Desai A, Chandra A, Thurairaja R, Dasgupta P, Khan MS, and Malde S
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local epidemiology, Retrospective Studies, Treatment Outcome, Cystectomy mortality, Urinary Bladder Neoplasms mortality, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms surgery
- Abstract
Objectives: To determine if the presence of non-urothelial variant histology (NUVH) is associated with a poorer prognosis following radical cystectomy (RC) compared to pure urothelial carcinoma (PUC)., Patients and Methods: A prospectively maintained database of all patients undergoing RC at a high-volume regional tertiary bladder cancer service between January 2010 and January 2017 was retrospectively analysed looking for patients with NUVH. Multivariate Cox proportional hazards regression analysis was used to determine disease recurrence, overall survival and bladder cancer-specific survival, as well as lymph node positivity. Association of tumour stage was determined using chi-squared analysis., Results: In total, 430 patients underwent RC of which 73 (17%) had NUVH and 357 (83%) had PUC. The median (range) follow-up was 45.0 (8.5-100.2) months. The presence of NUVH was associated with both increased overall (hazard ratio [HR] 1.86, 95% confidence interval [CI] 1.21-2.85) and bladder cancer-specific mortality (HR 1.81, 95% CI 1.91-3.01), as well as disease recurrence (HR 1.71, 95% CI 1.06-2.75) in multivariate analysis. Squamous cell variant was also associated with increased overall mortality (HR 1.91, 95% CI 1.16-3.13), cancer-specific mortality (HR 2.03, 95% CI 1.21-3.42) and disease recurrence (HR 2.08, 95% CI 1.23-3.52), although this was not seen in other variant subtypes. Lymph node positivity was not associated with NUVH in multivariate analysis (HR 1.28, 95% CI 0.59-2.75), but NUVH was associated with advanced tumour stage on chi-squared analysis (P < 0.001)., Conclusion: Our results showed a risk of shorter survival in NUVH compared to PUC. This suggests NUVH as an independent predictor of worse outcomes. As a result, patients with NUVH should be counselled preoperatively that overall and disease-specific outcomes are worse postoperatively and about the possible need for adjuvant treatment., (© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
42. NICE guidelines on prostate cancer 2019.
- Author
-
Dasgupta P, Davis J, and Hughes S
- Subjects
- Humans, Male, United Kingdom, Practice Guidelines as Topic, Prostatic Neoplasms diagnosis, Prostatic Neoplasms therapy
- Published
- 2019
- Full Text
- View/download PDF
43. Radical cystectomy complications and perioperative mortality.
- Author
-
Hampson A, Vincent A, Dasgupta P, and Vasdev N
- Subjects
- Humans, Perioperative Period, Cystectomy, Urinary Bladder Neoplasms surgery
- Published
- 2019
- Full Text
- View/download PDF
44. Prostate cancer screening: where are we now?
- Author
-
Light A, Elhage O, Marconi L, and Dasgupta P
- Subjects
- Humans, Male, Prostatic Neoplasms mortality, Early Detection of Cancer, Prostatic Neoplasms diagnosis
- Published
- 2019
- Full Text
- View/download PDF
45. Comparison of testis cancer-specific survival: an analysis of national cancer registry data from the USA, UK and Germany.
- Author
-
Withington J, Cole AP, Meyer CP, Seisen T, Schmid M, Lipsitz SR, Sweeney CJ, Dasgupta P, and Trinh QD
- Subjects
- Adolescent, Adult, Germany epidemiology, Health Status Disparities, Humans, Male, Mass Screening, Middle Aged, Needs Assessment, Neoplasm Staging, Predictive Value of Tests, Registries, Survival Analysis, Testicular Neoplasms diagnosis, United Kingdom epidemiology, United States epidemiology, Young Adult, Medically Uninsured statistics & numerical data, Testicular Neoplasms mortality
- Published
- 2019
- Full Text
- View/download PDF
46. #Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
- Author
-
Dhariwal R, Pindoria N, Dasgupta P, and Khan MS
- Subjects
- Antibodies, Monoclonal, Humanized, B7-H1 Antigen antagonists & inhibitors, CTLA-4 Antigen antagonists & inhibitors, Humans, Programmed Cell Death 1 Receptor antagonists & inhibitors, Antibodies, Monoclonal therapeutic use, Antineoplastic Agents, Immunological therapeutic use, Carcinoma, Transitional Cell drug therapy, Carcinoma, Transitional Cell secondary, Urinary Bladder Neoplasms pathology
- Published
- 2019
- Full Text
- View/download PDF
47. Cognitive training for technical and non-technical skills in robotic surgery: a randomised controlled trial.
- Author
-
Raison N, Ahmed K, Abe T, Brunckhorst O, Novara G, Buffi N, McIlhenny C, van der Poel H, van Hemelrijck M, Gavazzi A, and Dasgupta P
- Subjects
- Anastomosis, Surgical standards, Cognition, Education, Medical, Continuing, Educational Measurement, Humans, Minimally Invasive Surgical Procedures standards, Program Evaluation, Reproducibility of Results, Robotic Surgical Procedures standards, Task Performance and Analysis, Anastomosis, Surgical education, Clinical Competence, Computer Simulation, Minimally Invasive Surgical Procedures education, Robotic Surgical Procedures education, Surgeons education
- Abstract
Objective: To investigate the effectiveness of motor imagery (MI) for technical skill and non-technical skill (NTS) training in minimally invasive surgery (MIS)., Subjects and Methods: A single-blind, parallel-group randomised controlled trial was conducted at the Vattikuti Institute of Robotic Surgery, King's College London. Novice surgeons were recruited by open invitation in 2015. After basic robotic skills training, participants underwent simple randomisation to either MI training or standard training. All participants completed a robotic urethrovesical anastomosis task within a simulated operating room. In addition to the technical task, participants were required to manage three scripted NTS scenarios. Assessment was performed by five blinded expert surgeons and a NTS expert using validated tools for evaluating technical skills [Global Evaluative Assessment of Robotic Skills (GEARS)] and NTS [Non-Technical Skills for Surgeons (NOTSS)]. Quality of MI was assessed using a revised Movement Imagery Questionnaire (MIQ)., Results: In all, 33 participants underwent MI training and 29 underwent standard training. Interrater reliability was high, Krippendorff's α = 0.85. After MI training, the mean (sd) GEARS score was significantly higher than after standard training, at 13.1 (3.25) vs 11.4 (2.97) (P = 0.03). There was no difference in mean NOTSS scores, at 25.8 vs 26.4 (P = 0.77). MI training was successful with significantly higher imagery scores than standard training (mean MIQ score 5.1 vs 4.5, P = 0.04)., Conclusions: Motor imagery is an effective training tool for improving technical skill in MIS even in novice participants. No beneficial effect for NTS was found., (© 2018 The Authors BJU International © 2018 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
48. Science, technology and artificial intelligence.
- Author
-
Dasgupta P
- Subjects
- Algorithms, Humans, Urology standards, Artificial Intelligence, Science, Technology, Urology trends
- Published
- 2018
- Full Text
- View/download PDF
49. Three-dimensional printing in robot-assisted radical prostatectomy - an Idea, Development, Exploration, Assessment, Long-term follow-up (IDEAL) Phase 2a study.
- Author
-
Chandak P, Byrne N, Lynch H, Allen C, Rottenberg G, Chandra A, Raison N, Ahmed H, Kasivisvanathan V, Elhage O, and Dasgupta P
- Subjects
- Aged, Follow-Up Studies, Humans, Magnetic Resonance Imaging methods, Male, Middle Aged, Models, Anatomic, Pilot Projects, Prospective Studies, Prostate pathology, Prostate surgery, Printing, Three-Dimensional, Prostatectomy methods, Prostatic Neoplasms surgery, Robotic Surgical Procedures methods
- Published
- 2018
- Full Text
- View/download PDF
50. The Internet of Skills: use of fifth-generation telecommunications, haptics and artificial intelligence in robotic surgery.
- Author
-
Kim SSY, Dohler M, and Dasgupta P
- Subjects
- Artificial Intelligence, Humans, Internet, Telecommunications, Robotic Surgical Procedures methods, Robotics methods, Telemedicine methods
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.